Target Pain Score for Hydromorphone in Pancreatitis Management

Pain Assessment and Initial Management

The American College of Emergency Physicians and other guideline societies recommend that pain is the cardinal symptom of acute pancreatitis and its relief is a clinical priority 1
For patients experiencing pain intensity ≥4 (on a 0-10 scale), or pain <4 that interferes with function, prompt intervention with hydromorphone is indicated, as recommended by the National Comprehensive Cancer Network 2, 3
Hydromorphone is preferred over morphine or fentanyl in non-intubated pancreatitis patients, according to the World Journal of Emergency Surgery 1

For opioid-naïve patients with moderate to severe pancreatitis pain, the initial dose of IV hydromorphone is 1-2 mg, as recommended by the Journal of the National Comprehensive Cancer Network 3, 4
Pain should be reassessed every 15 minutes after IV administration, according to the National Comprehensive Cancer Network 2, 4
If pain score remains unchanged or increases after initial dose, the dose should be increased by 50-100% of previous dose, as recommended by the National Comprehensive Cancer Network 2, 3

For opioid-tolerant patients, the previous 24-hour opioid requirement should be calculated, and the rescue dose should be increased by 10-20% to achieve adequate analgesia, according to the National Comprehensive Cancer Network 3, 5
Equianalgesic dosing should be used when converting from other opioids, with 10 mg IV morphine equivalent to 2 mg IV hydromorphone, as recommended by the National Comprehensive Cancer Network 5

Vital signs should be monitored continuously in high dependency care unit if organ dysfunction occurs, according to the World Journal of Emergency Surgery 1
Common opioid-related adverse effects, such as constipation, respiratory depression, and nausea/vomiting, should be watched for and managed accordingly, as recommended by the National Comprehensive Cancer Network 1, 2, 3, 6